Groups information

Group name

Group 2

Groups definition

patients underwent PSA testing at a clinical urological practice (group 2).

Baseline information

Age

67 (63 70)

Age p-value

<0.001

PSA

8.13 (5.93 12.0)

PSA p-value

<0.001

Prostate weight (g)

35.3 (26.5 49.0)

Prostate volume p-value

<0.001

No of total biopsy cores, median (IQR)

12 (12 12)

No of positive cores, median (IQR)

3 (2 5)

Percent postive cores, median (range)

25 (13 42)

American Society of Aneshesiologists (ASA) physical status classification
Charlson comorbidity index (CCI)
Risk classification

low

77 (16.6%)

intermediate

240 (51.7%)

high

147 (31.7%)

Risk remark

D'Amico risk class